glp-1 brain inflammation Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease GLP-1 Medications: A Game Changer

The ethanol (ulcer) group had a significantly lower gastric pH than the control group

Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2

Serena Williams opens up about GLP-1 weight loss in new Ro ad August 21, 2025 10:43 AM EDT Featured Stories Grading 6 purpose marketing adsexpert weighs in on Claude, Polaroid and more Purpose marketing expert Thomas Kolster on what works, and does not work, on recent purpose ads.

Another point that catches my attention is the way Pravada structures its manufacturing programs

health system an estimated $173 billion annually, with $1,800$3,000 in additional medical costs per adult each year